Journey Medical Corp Deferred Federal Income Tax Expense (Benefit)
Journey Medical Corp (DERM) reported Deferred Federal Income Tax Expense (Benefit) of -$2.22 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-03-26
- Journey Medical Corp deferred federal income tax expense (benefit) for fiscal 2025 was -$2.22M.
- Journey Medical Corp deferred federal income tax expense (benefit) for fiscal 2024 was -$2.70M.
- Journey Medical Corp deferred federal income tax expense (benefit) for fiscal 2023 was -$753.00K.
- Journey Medical Corp deferred federal income tax expense (benefit) for fiscal 2022 was -$6.70M.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$2.22M 10-K · filed 2026-03-26 |
| 2024-12-31 | -$2.70M 10-K · filed 2026-03-26 |
| 2023-12-31 | -$753.00K 10-K · filed 2025-03-27 |
| 2022-12-31 | -$6.70M 10-K · filed 2024-03-29 |
| 2021-12-31 | -$7.83M 10-K · filed 2023-03-31 |
| 2020-12-31 | -$234.00K 10-K · filed 2022-03-28 |